Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore.

Vitamin D is known for maintaining Ca homeostasis and bone structure, and may also decrease susceptibility to chronic and infectious diseases. However, data on vitamin D status and its predictors among Southeast Asian populations are limited. We evaluated the distribution and determinants (genetic and environmental) of serum 25-hydroxyvitamin D (25(OH)D) concentrations among 504 middle-aged and elderly participants (aged 45-74 years) in the Singapore Chinese Health Study. Data on dietary and other lifestyle factors were collected by trained interviewers. Serum 25(OH)D concentrations and genetic polymorphisms in vitamin D metabolism pathway enzymes (cytochrome P450 (CYP) 2R1, 3A4, 27B1, 24A1; vitamin D binding protein (also known as group-specific component, GC); and vitamin D receptor) were measured using stored biospecimens. Mean 25(OH)D concentration was 68·8 nmol/l. Serum 25(OH)D concentrations were positively associated with dietary vitamin D intake, and inversely associated with hours spent sitting at work. BMI was not associated with 25(OH)D concentrations. CYP2R1 rs10741657, rs12794714, rs1993116; CYP3A4 rs2242480; and GC rs4588, rs7041, rs16847015, rs2298849 were statistically significantly associated with 25(OH)D concentrations. Individuals with the Gc2-2 haplotype (rs4588AA/rs7041TT) had statistically significantly lower 25(OH)D concentrations compared to all other Gc haplotypes (P-trend < 0·001). The majority of participants (86 %) had 25(OH)D concentrations ≥ 50 nmol/l, which is consistent with the 2011 Institute of Medicine (US) recommendation for bone health, and 32 % had concentrations of ≥ 75 nmol/l that are thought to be required for broader health effects. Dietary vitamin D intake, hours spent indoors at work and genetic variation in CYP2R1, CYP3A4 and GC are significant predictors of 25(OH)D concentrations among Singapore Chinese.

[1]  F. Moy,et al.  High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia , 2011, BMC public health.

[2]  Toshiko Tanaka,et al.  Genome-wide association study of circulating retinol levels , 2011, Human molecular genetics.

[3]  A. Norman.  Vitamin D nutrition is at a crossroads , 2011, Public Health Nutrition.

[4]  G. Schwalfenberg,et al.  A Canadian response to the 2010 Institute of Medicine vitamin D and calcium guidelines , 2011, Public Health Nutrition.

[5]  C. Sempos,et al.  Vitamin D status: United States, 2001-2006. , 2011, NCHS data brief.

[6]  R. Heaney,et al.  Why the IOM recommendations for vitamin D are deficient , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  I. Schuster.  Cytochromes P450 are essential players in the vitamin D signaling system. , 2011, Biochimica et biophysica acta.

[8]  B. Boucher.  Vitamin D insufficiency and diabetes risks. , 2011, Current drug targets.

[9]  Christine L. Taylor,et al.  Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .

[10]  J. Vacek,et al.  Role of vitamin D in cardiovascular health. , 2010, The American journal of cardiology.

[11]  R. Recker,et al.  Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects , 2010, Human Genetics.

[12]  C. Mathieu,et al.  Vitamin D: modulator of the immune system. , 2010, Current opinion in pharmacology.

[13]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[14]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010, American journal of epidemiology.

[15]  K. Dodd,et al.  Estimation of total usual calcium and vitamin D intakes in the United States. , 2010, The Journal of nutrition.

[16]  K. Phinney,et al.  Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. , 2010, Analytical chemistry.

[17]  M. Decramer,et al.  Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene , 2009, Thorax.

[18]  D. Cole,et al.  Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. , 2009, Clinical biochemistry.

[19]  A. Hofman,et al.  Vitamin D Binding Protein Genotype and Osteoporosis , 2009, Calcified Tissue International.

[20]  R. Hayes,et al.  Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. , 2009, Carcinogenesis.

[21]  M. Wjst,et al.  Serum 25‐hydroxyvitamin D and IgE – a significant but nonlinear relationship , 2009, Allergy.

[22]  P. Menheere,et al.  Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis , 2009, Journal of Neuroimmunology.

[23]  J. Brisson,et al.  Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. , 2009, The American journal of clinical nutrition.

[24]  B. Clarke,et al.  Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures , 2009 .

[25]  Wei Zhang,et al.  CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients , 2009, European Journal of Clinical Pharmacology.

[26]  J. Norris,et al.  Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[27]  A. LaCroix,et al.  Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures , 2008, Annals of Internal Medicine.

[28]  K. Badenhoop,et al.  Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms , 2008, Diabetes, obesity & metabolism.

[29]  B. Hollis.  Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. , 2008, The American journal of clinical nutrition.

[30]  A. Morris,et al.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis , 2008, The American journal of clinical nutrition.

[31]  M. Holick,et al.  Analyzing vitamin D in foods and supplements: methodologic challenges. , 2008, The American journal of clinical nutrition.

[32]  J. Chang-Claude,et al.  The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status , 2008, Cancer Epidemiology Biomarkers & Prevention.

[33]  Z. Hochberg,et al.  Rickets in the Middle East: role of environment and genetic predisposition. , 2008, The Journal of clinical endocrinology and metabolism.

[34]  M. Klebanoff,et al.  Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years , 2008, British Journal of Nutrition.

[35]  J. Holden,et al.  Vitamin D in foods: development of the US Department of Agriculture database. , 2008, The American journal of clinical nutrition.

[36]  C. McCarty,et al.  Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2008, Cancer Epidemiology Biomarkers & Prevention.

[37]  G. Khor,et al.  Vitamin D status and its association with parathyroid hormone concentrations in women of child-bearing age living in Jakarta and Kuala Lumpur , 2008, European Journal of Clinical Nutrition.

[38]  J. Chang-Claude,et al.  Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. , 2007, Carcinogenesis.

[39]  K. Badenhoop,et al.  CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans , 2007, Diabetes/metabolism research and reviews.

[40]  A. Douvdevani,et al.  RETRACTED: The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  W. Willett,et al.  The urgent need to recommend an intake of vitamin D that is effective. , 2007, The American journal of clinical nutrition.

[42]  M. Speeckaert,et al.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[43]  M. Hill,et al.  Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause , 2006, Clinical chemistry and laboratory medicine.

[44]  K. Badenhoop,et al.  Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[45]  N. Tandon,et al.  Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. , 2006, The American journal of clinical nutrition.

[46]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[47]  Audrey Lemaçon,et al.  Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. , 2005, Human molecular genetics.

[48]  W. Willett,et al.  Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[49]  D. Black,et al.  Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. , 2005, Clinical chemistry.

[50]  P. Vestergaard,et al.  Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.

[51]  D. Rao,et al.  Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. , 2004, Clinical biochemistry.

[52]  J. Zerwekh.  The measurement of vitamin D: analytical aspects , 2004, Annals of clinical biochemistry.

[53]  E. Gunter,et al.  Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[54]  S. Chan,et al.  Vitamin D status among postmenopausal Malaysian women. , 2004, Asia Pacific journal of clinical nutrition.

[55]  Woon-Puay Koh,et al.  Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. , 2003, Cancer research.

[56]  V. Choo.  WHO reassesses appropriate body-mass index for Asian populations , 2002, The Lancet.

[57]  G. Hitman,et al.  Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. , 2002, Diabetes.

[58]  P. Vestergaard,et al.  Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. , 2001, Clinical chemistry.

[59]  D O Stram,et al.  Singapore Chinese Health Study: Development, Validation, and Calibration of the Quantitative Food Frequency Questionnaire , 2001, Nutrition and cancer.

[60]  D. Hunter,et al.  Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[61]  S. Daiger,et al.  Heritability of quantitative variation at the group-specific component (Gc) locus. , 1984, American journal of human genetics.

[62]  J. Constans,et al.  Unusual sialilation of the serum DBP associated with the Gc 1 allele in alcoholic cirrhosis of the liver. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[63]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[64]  A. Sood,et al.  Vitamin D binding globulin phenotypes in liver disease. , 1979, Clinica chimica acta; international journal of clinical chemistry.